821-500
Astrocyte Growth Medium (500 ml)
Synonym(e):
Astrocyte Medium
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
12352207
NACRES:
NA.71
Empfohlene Produkte
Form
liquid
Haltbarkeit
6 mo.
Hersteller/Markenname
Cell Applications, Inc
Versandbedingung
wet ice
Lagertemp.
2-8°C
Allgemeine Beschreibung
Astrocyte growth medium is an all-in-one ready-to-use media, which is optimized for the characteristics and requirements unique to human astrocytes.
Anwendung
Astrocyte growth medium (500 ml) has been used to culture and maintain normal human astrocytes.
Qualität
Each lot was tested for the ability to support plating, spreading and proliferation
Angaben zur Herstellung
contained in protocol
Lagerklassenschlüssel
12 - Non Combustible Liquids
WGK
WGK 1
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Yi-Ting Lin et al.
Journal of clinical medicine, 8(2) (2019-02-16)
Uremic toxins accumulated in chronic kidney disease (CKD) increases the risk of cognitive impairment. Indoxyl sulfate (IS) is a well-known protein-bound uremic toxin that is correlated with several systemic diseases, but no studies on human brain cells are available. We
Jiaxin Sun et al.
Scientific reports, 10(1), 13899-13899 (2020-08-19)
Metabolic reprogramming in cancer cells, vs. non-cancer cells, elevates levels of reactive oxygen species (ROS) leading to higher oxidative stress. The elevated ROS levels suggest a vulnerability to excess prooxidant loads leading to selective cell death, a therapeutically exploitable difference.
Iris Maria Forte et al.
International journal of oncology, 54(6), 2189-2199 (2019-05-14)
Glioblastoma (GB) is the most common and aggressive malignant tumor of the central nervous system. Despite current intensive treatment regimens, consisting of surgical resection followed by radiotherapy with concomitant and adjuvant temozolomide (TMZ) chemotherapy, the prognosis of patients with GB remains
Protokolle
Store the cryovials in a liquid nitrogen storage tank immediately upon arrival.
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.